Do ultrathin strut bare-metal stents with passive coating improve efficacy in large coronary arteries? Insights from the randomized, multicenter BASKET-PROVE trials

Table 3 Discharge medication

	Silicon carbide-coated BMS	Uncoated cobalt-chromium BMS	P-value
Patients, no.	761	765
Aspirin	757 (99.5)	764 (99.9)	0.37
P2Y12-inhibitor^a	757 (99.5)	764 (99.9)	0.37
Anticoagulation therapy^b	29 (3.8)	34 (4.5)	0.63
Statin	715 (94.3)	706 (93.0)	0.35
Antithrombotic strategies
Dual antiplatelet therapy	754 (99.1)	763 (99.7)	0.18
Triple therapy^a	27 (3.6)	34 (4.5)	0.45

ISSN: 1471-2261